fda d.i.s.c.o.: first biosimilar approval for the treatment of cancer
Published 4 months ago • 74 plays • Length 8:31Download video MP4
Download video MP3
Similar videos
-
8:31
fda d.i.s.c.o.: first biosimilar approval for the treatment of cancer
-
1:58
fda review and approval process for biosimilar medications
-
4:01
fda d.i.s.c.o. burst edition: fda approval of tibsovo (ivosidenib) in combination with azacitidin...
-
2:47
biosimilars: approval process
-
3:21
fda d.i.s.c.o.: intro by dr. richard pazdur
-
4:12
the basics of biosimilars
-
6:01
fda d.i.s.c.o.: osimertinib for non-small cell lung cancer
-
42:08
how to interpret the gi360™
-
8:21
fda approval of a biosimilar, priority review in epithelioid sarcoma, and more
-
3:02
biosimilar medications — what patients need to know
-
2:04
the impact of the fda's approval of the first 'biosimilar' drug
-
2:04
opioid use disorder, new biosimilar, black family cancer awareness week, & more | in your day ep. 6
-
5:20
data requirements for biosimilars
-
4:20
the biosimilar development process
-
6:01
fda d.i.s.c.o.: first tissue/site agnostic cancer treatment approval
-
1:36
a look at the expansion of a biosimilar’s fda label with sue naeyaert
-
0:31
biosimilar medications: as identical twins explain, biosimilars have the same benefits (30 sec.)
-
0:16
biosimilar medications: as identical twins explain, biosimilars have the same benefits (15 sec.)
-
3:07
the promise of biosimilars